Cargando…

CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer

The cyclin-dependent kinase inhibitor 3 (CDKN3) gene, involved in mitosis, is upregulated in cervical cancer (CC). We investigated CDKN3 mRNA as a survival biomarker and potential therapeutic target for CC. CDKN3 mRNA was measured in 134 CC and 25 controls by quantitative PCR. A 5-year survival stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barrón, Eira Valeria, Roman-Bassaure, Edgar, Sánchez-Sandoval, Ana Laura, Espinosa, Ana María, Guardado-Estrada, Mariano, Medina, Ingrid, Juárez, Eligia, Alfaro, Ana, Bermúdez, Miriam, Zamora, Rubén, García-Ruiz, Carlos, Gomora, Juan Carlos, Kofman, Susana, Pérez-Armendariz, E. Martha, Berumen, Jaime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570808/ https://www.ncbi.nlm.nih.gov/pubmed/26372210 http://dx.doi.org/10.1371/journal.pone.0137397

Ejemplares similares

Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study
por: Medina-Martinez, Ingrid, et al.
Publicado: (2014)

The Distribution of High-Risk Human Papillomaviruses Is Different in Young and Old Patients with Cervical Cancer
por: Guardado-Estrada, Mariano, et al.
Publicado: (2014)

Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer
por: Alfaro, Ana, et al.
Publicado: (2016)

Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer
por: Espinosa, Ana María, et al.
Publicado: (2013)

Correction: Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer
por: Espinosa, Ana María, et al.
Publicado: (2013)

Amplified Genes May Be Overexpressed, Unchanged, or Downregulated in Cervical Cancer Cell Lines
por: Vazquez-Mena, Oscar, et al.
Publicado: (2012)

The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients
por: Bolaños‐Suárez, Verónica, et al.
Publicado: (2023)

The invasiveness of human cervical cancer associated to the function of Na(V)1.6 channels is mediated by MMP-2 activity
por: Lopez-Charcas, Osbaldo, et al.
Publicado: (2018)

Contribution of voltage-gated sodium channel β-subunits to cervical cancer cells metastatic behavior
por: Sanchez-Sandoval, Ana Laura, et al.
Publicado: (2019)

Voltage-gated sodium channels: from roles and mechanisms in the metastatic cell behavior to clinical potential as therapeutic targets
por: Sanchez-Sandoval, Ana Laura, et al.
Publicado: (2023)

COVID-19: critical case of a patient with an atypical manifestation of the disease
por: Barrón-Palma, Eira Valeria, et al.
Publicado: (2023)

Supervised Machine Learning Methods for Seasonal Influenza Diagnosis
por: Marquez, Edna, et al.
Publicado: (2023)

Contribution of S4 segments and S4-S5 linkers to the low-voltage activation properties of T-type Ca(V)3.3 channels
por: Sanchez-Sandoval, Ana Laura, et al.
Publicado: (2018)

Increase of Ca(V)3 channel activity induced by HVA β1b-subunit is not mediated by a physical interaction
por: Arteaga-Tlecuitl, Rogelio, et al.
Publicado: (2018)

Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
por: Sandoval-Rodriguez, Ana, et al.
Publicado: (2022)

Transcriptional regulation of CDKN2A/p16 by sirtuin 7 in senescence
por: Rodríguez, Sergio, et al.
Publicado: (2022)

El aprendizaje de lenguas extranjeras y las tecnologías de la información : aprendizaje de próxima generación
por: Armendáriz, Ana
Publicado: (2005)

Loss of Both CDKN2A and CDKN2B Allows for Centrosome Overduplication in Melanoma
por: Patel, Shyamal, et al.
Publicado: (2020)

Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
por: Soto, José Luis, et al.
Publicado: (2005)

Clinical validation of 3D-printed swabs in adults and children for SARS-CoV-2 detection
por: Sanchez-Sandoval, Ana Laura, et al.
Publicado: (2023)

Loss of CDKN2A and CDKN2B expression is associated with disease recurrence in oral cancer
por: Deepak Roshan, V G, et al.
Publicado: (2019)

Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish population
por: Gutierrez-Camino, Angela, et al.
Publicado: (2017)

A miRNome analysis at the early postmortem interval
por: Guardado-Estrada, Mariano, et al.
Publicado: (2023)

Molecular Dynamics Simulations of HPr Proteins from a Thermophilic and a Mesophilic Organism: A Comparative Thermal Study
por: Gómez-Flores, Ana K., et al.
Publicado: (2023)

Roles of CDKN1B in cancer?
por: Belletti, Barbara, et al.
Publicado: (2015)

AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis
por: García-Bañuelos, Jesús, et al.
Publicado: (2023)

The multifaceted role of pirfenidone and its novel targets
por: Macías-Barragán, José, et al.
Publicado: (2010)

Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma
por: Jalili, Ahmad, et al.
Publicado: (2012)

Molecular Genetics and Functional Analysis Implicate CDKN2BAS1-CDKN2B Involvement in POAG Pathogenesis
por: Rathi, Sonika, et al.
Publicado: (2020)

Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism
por: Mazarico-Altisent, I., et al.
Publicado: (2022)

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
por: Genescà, E., et al.
Publicado: (2018)

19q13.11 microdeletion concomitant with ins(2;19)(p25.3;q13.1q13.4)dn in a boy: potential role of UBA2 in the associated phenotype
por: Venegas-Vega, Carlos, et al.
Publicado: (2014)

Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours.
por: Schmidt, E. E., et al.
Publicado: (1997)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

The tumor suppressor CDKN3 controls mitosis
por: Nalepa, Grzegorz, et al.
Publicado: (2013)

Association Study of Genetic Variants in CDKN2A/CDKN2B Genes/Loci with Late-Onset Alzheimer's Disease
por: Tedde, Andrea, et al.
Publicado: (2011)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
por: Arya, Ashutosh Kumar, et al.
Publicado: (2017)

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma
por: Dai, Wei, et al.
Publicado: (2016)

Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier
por: Martínez de Juan, Fernando, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j40mr7156t7p7mc99shfs4qo5v